Cytokines and irritable bowel syndrome: Where do we stand?

Drossman, 1999, The functional gastrointestinal disorders and the Rome II process, Gut, 45, II1, 10.1136/gut.45.2008.ii1 Drossman, 2006, The functional gastrointestinal disorders and the Rome III process, Gastroenterology, 130, 1377, 10.1053/j.gastro.2006.03.008 Jones, 2006, Brain–gut connections in functional GI disorders: anatomic and physiologic relationships, Neurogastroenterol Motil, 18, 91, 10.1111/j.1365-2982.2005.00730.x Verdu, 2004, Microbial–gut interactions in health and disease. Irritable bowel syndrome, Best Pract Res Clin Gastroenterol, 18, 315, 10.1016/j.bpg.2003.11.003 Murch, 2006, Allergy and intestinal dysmotility – evidence of genuine causal linkage?, Curr Opin Gastroenterol, 22, 664, 10.1097/01.mog.0000245546.18279.7e Feinle-Bisset, 2004, Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia, Am J Gastroenterol, 99, 170, 10.1111/j.1572-0241.2004.04003.x Holtmann, 2004, Molecular basis of functional gastrointestinal disorders, Best Pract Res Clin Gastroenterol, 18, 633, 10.1016/j.bpg.2004.04.006 Ohman, 2010, Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions, Nat Rev Gastroenterol Hepatol, 7, 163, 10.1038/nrgastro.2010.4 Choung, 2011, Epidemiology of IBS, Gastroenterol Clin North Am, 40, 1, 10.1016/j.gtc.2010.12.006 Drossman, 2002, AGA technical review on irritable bowel syndrome, Gastroenterology, 123, 2108, 10.1053/gast.2002.37095 Spiller, 2009, Postinfectious irritable bowel syndrome, Gastroenterology, 136, 1979, 10.1053/j.gastro.2009.02.074 Barbara, 2009, Postinfectious irritable bowel syndrome, J Pediatr Gastroenterol Nutr, 48, S95, 10.1097/MPG.0b013e3181a15e2e Elsenbruch, 2004, Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome?, Am J Gastroenterol, 99, 703, 10.1111/j.1572-0241.2004.04138.x Liebregts, 2007, Immune activation in patients with irritable bowel syndrome, Gastroenterology, 132, 913, 10.1053/j.gastro.2007.01.046 Villani, 2010, Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis, Gastroenterology, 138, 1502, 10.1053/j.gastro.2009.12.049 Barkhordari, 2010, T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome, Inflammation, 33, 281, 10.1007/s10753-010-9183-6 Barkhordari, 2010, Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome, J Clin Immunol, 30, 74, 10.1007/s10875-009-9342-4 Resch, 2005, Cytokines, 45 Sivalingam, 2007, In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis, Ann Acad Med Singapore, 36, 96, 10.47102/annals-acadmedsg.V36N2p96 Brand, 2009, Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease, Gut, 58, 1152, 10.1136/gut.2008.163667 O’Mahony, 2005, Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, 128, 541, 10.1053/j.gastro.2004.11.050 Dinan, 2006, Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?, Gastroenterology, 130, 304, 10.1053/j.gastro.2005.11.033 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat Rev Neurosci, 9, 46, 10.1038/nrn2297 Tracey, 2002, The inflammatory reflex, Nature, 420, 853, 10.1038/nature01321 Dinan, 2008, Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors, Am J Gastroenterol, 103, 2570, 10.1111/j.1572-0241.2008.01871.x Kindt, 2009, Immune dysfunction in patients with functional gastrointestinal disorders, Neurogastroenterol Motil, 21, 389, 10.1111/j.1365-2982.2008.01220.x Ohman, 2009, T-cell activation in patients with irritable bowel syndrome, Am J Gastroenterol, 104, 1205, 10.1038/ajg.2009.116 Scully, 2010, Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity, Am J Gastroenterol, 105, 2235, 10.1038/ajg.2010.159 Goral, 2010, Mast cells count and serum cytokine levels in patients with irritable bowel syndrome, Hepatogastroenterology, 57, 751 Hua, 2011, Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome, J Pediatr Gastroenterol Nutr, 52, 376, 10.1097/MPG.0b013e3181fd9816 McKernan, 2011, Altered peripheral toll-like receptor responses in the irritable bowel syndrome, Aliment Pharmacol Ther, 33, 1045, 10.1111/j.1365-2036.2011.04624.x Del Valle-Pinero, 2011, Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study, Neurogastroenterol Motil, 23, 1092, 10.1111/j.1365-2982.2011.01792.x Gwee, 2003, Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome, Gut, 52, 523, 10.1136/gut.52.4.523 Macsharry, 2008, Mucosal cytokine imbalance in irritable bowel syndrome, Scand J Gastroenterol, 43, 1467, 10.1080/00365520802276127 Gonsalkorale, 2003, Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?, Gut, 52, 91, 10.1136/gut.52.1.91 van der Veek, 2005, Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome, Am J Gastroenterol, 100, 2510, 10.1111/j.1572-0241.2005.00257.x Barkhordari, 2011, Lack of association between interleukin 12 C (−1188) a polymorphism and irritable bowel syndrome, Avicenna J Med Biotech, 3, 45 Santhosh, 2010, Cytokine gene polymorphisms in irritable bowel syndrome in Indian population – a pilot case control study, Trop Gastroenterol, 31, 30 Lee, 2010, G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome, Neurogastroenterol Motil, 22, 758, 10.1111/j.1365-2982.2010.01496.x Zucchelli, 2011, Association of TNFSF15 polymorphism with irritable bowel syndrome, Gut, 10.1136/gut.2011.241877 Goyal, 1996, The enteric nervous system, N Engl J Med, 334, 1106, 10.1056/NEJM199604253341707 O’Mahony, 2011, Maternal separation as a model of brain–gut axis dysfunction, Psychopharmacology (Berl), 214, 71, 10.1007/s00213-010-2010-9 Qin, 2011, Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome, J Gastroenterol, 46, 164, 10.1007/s00535-010-0321-6 Annahazi, 2009, Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice, Pain, 144, 209, 10.1016/j.pain.2009.04.017 Buhner, 2009, Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome, Gastroenterology, 137, 1425, 10.1053/j.gastro.2009.07.005 Tjwa, 2003, Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon, Am J Physiol Gastrointest Liver Physiol, 285, G1268, 10.1152/ajpgi.00073.2003 Kelles, 2000, IL-1beta and IL-6 excite neurones and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig, Neurogastroenterol Motil, 12, 531, 10.1046/j.1365-2982.2000.00228.x Fargeas, 1993, Central action of interleukin 1 beta on intestinal motility in rats: mediation by two mechanisms, Gastroenterology, 104, 377, 10.1016/0016-5085(93)90404-Z Murakami, 2008, Interleukin-1beta enhances the action of bradykinin in rat myenteric neurons through up-regulation of glial B1 receptor expression, Neuroscience, 151, 222, 10.1016/j.neuroscience.2007.09.065 Kindt, 2010, Prolonged IL-1beta exposure alters neurotransmitter and electrically induced Ca(2+) responses in the myenteric plexus, Neurogastroenterol Motil, 22, 321, 10.1111/j.1365-2982.2009.01414.x Khan, 2001, IL-12 gene transfer alters gut physiology and host immunity in nematode-infected mice, Am J Physiol Gastrointest Liver Physiol, 281, G102, 10.1152/ajpgi.2001.281.1.G102 Bashashati, 2011, Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in the mouse, Br J Pharmacol, 10.1111/j.1476-5381.2011.01644.x Goldhill, 1997, Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle, Am J Physiol, 272, G1135 Akiho, 2005, Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction, Gastroenterology, 129, 131, 10.1053/j.gastro.2005.03.049 Akiho, 2002, Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells, Am J Physiol Gastrointest Liver Physiol, 282, G226, 10.1152/ajpgi.2002.282.2.G226 Mizutani, 2010, Persistent gut motor dysfunction in a murine model of T-cell-induced enteropathy, Neurogastroenterol Motil, 22, 196, 10.1111/j.1365-2982.2009.01396.x Motomura, 2010, Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection, Am J Physiol Gastrointest Liver Physiol, 299, G1354, 10.1152/ajpgi.00324.2010 O’Mahony, 2009, Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses, Biol Psychiatry, 65, 263, 10.1016/j.biopsych.2008.06.026 O’Malley, 2011, Altered expression and secretion of colonic interleukin-6 in a stress-sensitive animal model of brain–gut axis dysfunction, J Neuroimmunol, 235, 48, 10.1016/j.jneuroim.2011.04.003 Loizzo, 2002, Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period, Br J Pharmacol, 135, 1219, 10.1038/sj.bjp.0704577 Bercik, 2004, Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction, Gastroenterology, 127, 179, 10.1053/j.gastro.2004.04.006 Coelho, 2000, Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve, Am J Physiol Gastrointest Liver Physiol, 279, G781, 10.1152/ajpgi.2000.279.4.G781 Bercik, 2010, Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice, Gastroenterology, 139, 2102, 10.1053/j.gastro.2010.06.063 Morrow, 1995, Interleukin-1 beta in the dorsal vagal complex inhibits TRH analogue-induced stimulation of gastric contractility, Am J Physiol, 269, G196 Plaza, 1997, Role of central interleukin-1 beta in gastrointestinal motor disturbances induced by lipopolysaccharide in sheep, Dig Dis Sci, 42, 242, 10.1023/A:1018837112572 Guerrero-Lindner, 2003, Central tumour necrosis factor-alpha mediates the early gastrointestinal motor disturbances induced by lipopolysaccharide in sheep, Neurogastroenterol Motil, 15, 307, 10.1046/j.1365-2982.2003.00402.x Riazi, 2010, Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability, Epilepsy Res, 89, 34, 10.1016/j.eplepsyres.2009.09.004 Galic, 2008, Postnatal inflammation increases seizure susceptibility in adult rats, J Neurosci, 28, 6904, 10.1523/JNEUROSCI.1901-08.2008 Piche, 2009, Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators, Gut, 58, 196, 10.1136/gut.2007.140806 Al-Sadi, 2009, Mechanism of cytokine modulation of epithelial tight junction barrier, Front Biosci, 14, 2765, 10.2741/3413 Shen, 2009, Mechanisms and functional implications of intestinal barrier defects, Dig Dis, 27, 443, 10.1159/000233282 Xia, 1999, IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system, J Clin Invest, 103, 1309, 10.1172/JCI5823 O’Malley, 2011, Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism, Am J Physiol Gastrointest Liver Physiol, 300, G241, 10.1152/ajpgi.00385.2010 Barreau, 2004, Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats, Gut, 53, 501, 10.1136/gut.2003.024174 Gareau, 2007, Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability, Am J Physiol Gastrointest Liver Physiol, 293, G198, 10.1152/ajpgi.00392.2006 Gareau, 2006, Neonatal maternal separation causes colonic dysfunction in rat pups including impaired host resistance, Pediatr Res, 59, 83, 10.1203/01.pdr.0000190577.62426.45 Ferrier, 2003, Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice, Gastroenterology, 125, 795, 10.1016/S0016-5085(03)01057-6 Rodriguez-Fandino, 2010, From cytokines to toll-like receptors and beyond – current knowledge and future research needs in irritable bowel syndrome, J Neurogastroenterol Motil, 16, 363, 10.5056/jnm.2010.16.4.363 Rautava, 2002, The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease, Curr Issues Intest Microbiol, 3, 15 Kiba, 2006, Relationships between the autonomic nervous system, humoral factors and immune functions in the intestine, Digestion, 74, 215, 10.1159/000100512 Mawe, 2009, Plasticity of enteric nerve functions in the inflamed and postinflamed gut, Neurogastroenterol Motil, 21, 481, 10.1111/j.1365-2982.2009.01291.x Lomax, 2005, Plasticity of the enteric nervous system during intestinal inflammation, Neurogastroenterol Motil, 17, 4, 10.1111/j.1365-2982.2004.00607.x Dinan, 2010, IBS: an epigenetic perspective, Nat Rev Gastroenterol Hepatol, 7, 465, 10.1038/nrgastro.2010.99